Whitepapers , Pediatrics

Strategies for Accelerating Pediatric Drug Development

Overview

In this whitepaper, Quotient Sciences highlights the key challenges that arise in pediatric formulation development, offers potential solutions, and discusses future trends and regulatory aspects that can help streamline pediatric medicines to patients faster.

Download
Ask The Experts

Pediatric drug development questions? Get answers from our team.

Have a question about your pediatric drug program? Ask a member of our team about our capabilities for drug product clinical manufacturing, commercial manufacturing, or clinical testing to keep your pediatric drug program on-track.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Nazim Kanji

Executive Director, Pediatric Services

Nazim Kanji has over 25 years of experience in the pharmaceutical and consumer healthcare industries, where he has worked in produ...

About Nazim
Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
Get in touch
Humanity can't afford to wait, so neither can we.